Epidemiology of community-acquired Pseudomonas aeruginosa infections in children

被引:17
作者
Paraskaki, I [1 ]
Lebessi, E [1 ]
Legakis, NJ [1 ]
机构
[1] UNIV ATHENS,P&A KYRIAKOU CHILDRENS HOSP,DEPT MICROBIOL,ATHENS 11527,GREECE
关键词
D O I
10.1007/BF01701519
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The epidemiology of community-acquired Pseudomonas aeruginosa infections in children during a one-year period (January through December 1993) was evaluated, A total of 6,859 clinical samples, each one representing a separate individual with suspected infection, were cultured. Pseudomonas aeruginosa was isolated from 218 children with various infections occurring in the following order of frequency: chronic suppurative otitis media, 76.3%; appendicitis/peritonitis, 10.3%; osteomyelitis, 8.9%; skin or soft tissue infection, 6.3%; acute conjunctivitis, 3.0%; and urinary tract infection, 0.1%. A variety of O serogroups were identified: O1 (15.2%), O6 (14.7%), O11 (12.4%), O10 (11.5%), O3 (10.6%), O5 (5.1%), and O9 (4.6%), Other serogroups and nontypable strains were recovered at a frequency of 11.2% and 14.7%, respectively, Nontypable strains predominated in chronic otitis media (18.9%), while serogroups O1 (18.3%), O6 (17.5%), and O11 (17.5%) were recovered most frequently among the typable isolates, Susceptibility of Pseudomonas aeruginosa to antipseudomonadal agents was extremely high. The rate of susceptibility to ceftazidime was 99.6%, to azlocillin 98.6%, to piperacillin 98.2%, to aztreonam 97.3%, to gentamicin and netilmicin 97.7%, and to ciprofloxacin 99.1%, All isolates were susceptible to tobramycin, imipenem, and amikacin. The results might suggest that community-acquired Pseudomonas aeruginosa infections in children can be treated successfully with any antipseudomonadal antibiotic.
引用
收藏
页码:782 / 786
页数:5
相关论文
共 28 条
[21]   CHRONIC SUPPURATIVE OTITIS-MEDIA [J].
NELSON, JD .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (06) :446-448
[22]  
PARASKAKI I, 1994, ACTA MICROBIOLOGICA, V39, P427
[23]   RESISTANCE MECHANISMS OF MULTIRESISTANT SEROTYPE 012 PSEUDOMONAS-AERUGINOSA ISOLATED IN EUROPE [J].
PITT, TL ;
LIVERMORE, DM ;
MILLER, G ;
VATOPOULOS, A ;
LEGAKIS, NJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (03) :319-328
[24]   POLYAGGLUTINATING AND NONTYPABLE STRAINS OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS [J].
PITT, TL ;
MACDOUGALL, J ;
PENKETH, ARL ;
COOKE, EM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1986, 21 (02) :179-186
[26]   RECENT ADVANCES IN TYPING OF PSEUDOMONAS-AERUGINOSA [J].
POH, CL ;
YEO, CC .
JOURNAL OF HOSPITAL INFECTION, 1993, 24 (03) :175-181
[27]  
POLLACK M, 1992, INFECT DIS, P1502
[28]   A 3-YEAR STUDY OF NOSOCOMIAL INFECTIONS ASSOCIATED WITH PSEUDOMONAS-AERUGINOSA [J].
SHERERTZ, RJ ;
SARUBBI, FA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 18 (01) :160-164